Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Express: The Key Role of Cytochrome C for Apoptosis Detection Using Raman Micro-Imaging in an Animal Model of Brain Ischemia with Insulin Treatment.

Russo V, Candeloro P, Malara N, Perozziello G, Iannone M, Scicchitano M, Mollace R, Musolino V, Gliozzi M, Carresi C, Morittu VM, Gratteri S, Palma E, Muscoli C, Di Fabrizio E, Mollace V.

Appl Spectrosc. 2019 Jun 20:3702819858671. doi: 10.1177/0003702819858671. [Epub ahead of print] No abstract available.

PMID:
31219322
2.

Waveguiding and SERS Simplified Raman Spectroscopy on Biological Samples.

Valpapuram I, Candeloro P, Coluccio ML, Parrotta EI, Giugni A, Das G, Cuda G, Di Fabrizio E, Perozziello G.

Biosensors (Basel). 2019 Mar 3;9(1). pii: E37. doi: 10.3390/bios9010037.

3.

Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumour.

Malara N, Gentile F, Coppedè N, Coluccio ML, Candeloro P, Perozziello G, Ferrara L, Giannetto M, Careri M, Castellini A, Mignogna C, Presta I, Pirrone CK, Maisano D, Donato A, Donato G, Greco M, Scumaci D, Cuda G, Casale F, Ferraro E, Bonacci S, Trunzo V, Mollace V, Onesto V, Majewska R, Amato F, Renne M, Innaro N, Sena G, Sacco R, Givigliano F, Voci C, Volpentesta G, Guzzi G, Lavano A, Scali E, Bottoni U, Di Fabrizio E.

NPJ Precis Oncol. 2018 Nov 19;2:26. doi: 10.1038/s41698-018-0069-7. eCollection 2018.

4.

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes.

Porcellati F, Lucidi P, Candeloro P, Cioli P, Marinelli Andreoli A, Curti G, Bolli GB, Fanelli CG.

Diabetes Care. 2019 Jan;42(1):85-92. doi: 10.2337/dc18-0706. Epub 2018 Oct 10.

PMID:
30305345
5.

Plasmonic Nanowires for Wide Wavelength Range Molecular Sensing.

Marinaro G, Das G, Giugni A, Allione M, Torre B, Candeloro P, Kosel J, Di Fabrizio E.

Materials (Basel). 2018 May 17;11(5). pii: E827. doi: 10.3390/ma11050827.

6.

Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy.

Parrotta E, De Angelis MT, Scalise S, Candeloro P, Santamaria G, Paonessa M, Coluccio ML, Perozziello G, De Vitis S, Sgura A, Coluzzi E, Mollace V, Di Fabrizio EM, Cuda G.

Stem Cell Res Ther. 2017 Nov 28;8(1):271. doi: 10.1186/s13287-017-0720-1.

7.

Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes.

Iaccino E, Mimmi S, Dattilo V, Marino F, Candeloro P, Di Loria A, Marimpietri D, Pisano A, Albano F, Vecchio E, Ceglia S, Golino G, Lupia A, Fiume G, Quinto I, Scala G.

Mol Cancer. 2017 Oct 13;16(1):159. doi: 10.1186/s12943-017-0730-8.

8.

An Overview of Lipid Droplets in Cancer and Cancer Stem Cells.

Tirinato L, Pagliari F, Limongi T, Marini M, Falqui A, Seco J, Candeloro P, Liberale C, Di Fabrizio E.

Stem Cells Int. 2017;2017:1656053. doi: 10.1155/2017/1656053. Epub 2017 Aug 13. Review.

9.

Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes.

Lucidi P, Porcellati F, Marinelli Andreoli A, Candeloro P, Cioli P, Bolli GB, Fanelli CG.

Diabetes Metab. 2018 Sep;44(4):368-372. doi: 10.1016/j.diabet.2017.05.004. Epub 2017 Jun 7.

PMID:
28599764
10.

Fabrication and Applications of Micro/Nanostructured Devices for Tissue Engineering.

Limongi T, Tirinato L, Pagliari F, Giugni A, Allione M, Perozziello G, Candeloro P, Di Fabrizio E.

Nanomicro Lett. 2017;9(1):1. doi: 10.1007/s40820-016-0103-7. Epub 2016 Aug 31. Review.

11.

Microfluidic device for continuous single cells analysis via Raman spectroscopy enhanced by integrated plasmonic nanodimers.

Perozziello G, Candeloro P, De Grazia A, Esposito F, Allione M, Coluccio ML, Tallerico R, Valpapuram I, Tirinato L, Das G, Giugni A, Torre B, Veltri P, Kruhne U, Della Valle G, Di Fabrizio E.

Opt Express. 2016 Jan 25;24(2):A180-90. doi: 10.1364/OE.24.00A180.

PMID:
26832572
12.

Detection of single amino acid mutation in human breast cancer by disordered plasmonic self-similar chain.

Coluccio ML, Gentile F, Das G, Nicastri A, Perri AM, Candeloro P, Perozziello G, Proietti Zaccaria R, Gongora JS, Alrasheed S, Fratalocchi A, Limongi T, Cuda G, Di Fabrizio E.

Sci Adv. 2015 Sep 4;1(8):e1500487. doi: 10.1126/sciadv.1500487. eCollection 2015 Sep.

13.

The structure of DNA by direct imaging.

Marini M, Falqui A, Moretti M, Limongi T, Allione M, Genovese A, Lopatin S, Tirinato L, Das G, Torre B, Giugni A, Gentile F, Candeloro P, Di Fabrizio E.

Sci Adv. 2015 Aug 28;1(7):e1500734. doi: 10.1126/sciadv.1500734. eCollection 2015 Aug.

14.

H ferritin silencing induces protein misfolding in K562 cells: A Raman analysis.

Zolea F, Biamonte F, Candeloro P, Di Sanzo M, Cozzi A, Di Vito A, Quaresima B, Lobello N, Trecroci F, Di Fabrizio E, Levi S, Cuda G, Costanzo F.

Free Radic Biol Med. 2015 Dec;89:614-23. doi: 10.1016/j.freeradbiomed.2015.07.161. Epub 2015 Oct 9.

PMID:
26454082
15.

Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.

Lucidi P, Porcellati F, Marinelli Andreoli A, Carriero I, Candeloro P, Cioli P, Bolli GB, Fanelli CG.

Diabetes Care. 2015 Dec;38(12):2204-10. doi: 10.2337/dc15-0801. Epub 2015 Sep 10.

PMID:
26358287
16.

Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin.

Lucidi P, Porcellati F, Yki-Järvinen H, Riddle MC, Candeloro P, Marinelli Andreoli A, Bolli GB, Fanelli CG.

Diabetes Care. 2015 Jul;38(7):e96-7. doi: 10.2337/dc14-2662. No abstract available.

PMID:
26106233
17.

Mechanical stress downregulates MHC class I expression on human cancer cell membrane.

La Rocca R, Tallerico R, Talib Hassan A, Das G, Lakshmikanth T, Matteucci M, Liberale C, Mesuraca M, Scumaci D, Gentile F, Cojoc G, Perozziello G, Ammendolia A, Gallo A, Kärre K, Cuda G, Candeloro P, Di Fabrizio E, Carbone E.

PLoS One. 2014 Dec 26;9(12):e111758. doi: 10.1371/journal.pone.0111758. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0118519. Tadepally, Lakshmikanth [corrected to Lakshmikanth, Tadepally].

18.

Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes.

Porcellati F, Lucidi P, Cioli P, Candeloro P, Marinelli Andreoli A, Marzotti S, Ambrogi M, Bolli GB, Fanelli CG.

Diabetes Care. 2015 Mar;38(3):503-12. doi: 10.2337/dc14-0649. Epub 2014 Dec 18.

PMID:
25524950
19.

Lipid droplets: a new player in colorectal cancer stem cells unveiled by spectroscopic imaging.

Tirinato L, Liberale C, Di Franco S, Candeloro P, Benfante A, La Rocca R, Potze L, Marotta R, Ruffilli R, Rajamanickam VP, Malerba M, De Angelis F, Falqui A, Carbone E, Todaro M, Medema JP, Stassi G, Di Fabrizio E.

Stem Cells. 2015 Jan;33(1):35-44. doi: 10.1002/stem.1837.

20.

Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells.

Malara N, Coluccio ML, Limongi T, Asande M, Trunzo V, Cojoc G, Raso C, Candeloro P, Perozziello G, Raimondo R, De Vitis S, Roveda L, Renne M, Prati U, Mollace V, Di Fabrizio E.

Small. 2014 Nov 12;10(21):4324-31. doi: 10.1002/smll.201400498. Epub 2014 Jul 14.

PMID:
25044603
21.

Selective on site separation and detection of molecules in diluted solutions with super-hydrophobic clusters of plasmonic nanoparticles.

Gentile F, Coluccio ML, Zaccaria RP, Francardi M, Cojoc G, Perozziello G, Raimondo R, Candeloro P, Di Fabrizio E.

Nanoscale. 2014 Jul 21;6(14):8208-25. doi: 10.1039/c4nr00796d.

PMID:
24930780
22.

Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response study.

Lucidi P, Porcellati F, Candeloro P, Cioli P, Andreoli AM, Marzotti S, Schmidt R, Bolli GB, Fanelli CG.

Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):709-16. doi: 10.1016/j.numecd.2014.02.008. Epub 2014 Feb 22.

PMID:
24702815
23.

Electroless deposition and nanolithography can control the formation of materials at the nano-scale for plasmonic applications.

Coluccio ML, Gentile F, Francardi M, Perozziello G, Malara N, Candeloro P, Di Fabrizio E.

Sensors (Basel). 2014 Mar 27;14(4):6056-83. doi: 10.3390/s140406056.

24.

Microtexturing of the conductive PEDOT:PSS polymer for superhydrophobic organic electrochemical transistors.

Gentile F, Coppedè N, Tarabella G, Villani M, Calestani D, Candeloro P, Iannotta S, Di Fabrizio E.

Biomed Res Int. 2014;2014:302694. doi: 10.1155/2014/302694. Epub 2014 Jan 22.

25.

Direct determination of the resonance properties of metallic conical nanoantennas.

Tuccio S, Razzari L, Alabastri A, Toma A, Liberale C, De Angelis F, Candeloro P, Das G, Giugni A, Di Fabrizio E, Zaccaria RP.

Opt Lett. 2014 Feb 1;39(3):571-3. doi: 10.1364/OL.39.000571.

PMID:
24487868
26.

Raman database of amino acids solutions: a critical study of extended multiplicative signal correction.

Candeloro P, Grande E, Raimondo R, Di Mascolo D, Gentile F, Coluccio ML, Perozziello G, Malara N, Francardi M, Di Fabrizio E.

Analyst. 2013 Nov 12;138(24):7331-40. doi: 10.1039/c3an01665j.

PMID:
24153318
27.

Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity.

Di Mascolo D, J Lyon C, Aryal S, Ramirez MR, Wang J, Candeloro P, Guindani M, Hsueh WA, Decuzzi P.

J Control Release. 2013 Sep 28;170(3):460-8. doi: 10.1016/j.jconrel.2013.06.012. Epub 2013 Jun 18.

28.

Microfluidic biofunctionalisation protocols to form multi-valent interactions for cell rolling and phenotype modification investigations.

Perozziello G, Simone G, Malara N, La Rocca R, Tallerico R, Catalano R, Pardeo F, Candeloro P, Cuda G, Carbone E, Di Fabrizio E.

Electrophoresis. 2013 Jul;34(13):1845-51. doi: 10.1002/elps.201300106.

PMID:
23616364
29.

Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes.

Lucidi P, Porcellati F, Rossetti P, Candeloro P, Andreoli AM, Cioli P, Hahn A, Schmidt R, Bolli GB, Fanelli CG.

Diabetes Care. 2012 Dec;35(12):2647-9. doi: 10.2337/dc12-0271. Epub 2012 Oct 18.

30.

Microfluidic devices modulate tumor cell line susceptibility to NK cell recognition.

Perozziello G, La Rocca R, Cojoc G, Liberale C, Malara N, Simone G, Candeloro P, Anichini A, Tirinato L, Gentile F, Coluccio ML, Carbone E, Di Fabrizio E.

Small. 2012 Sep 24;8(18):2886-94. doi: 10.1002/smll.201200160. Epub 2012 Jul 3.

PMID:
22761002
31.

Superhydrophobic surfaces as smart platforms for the analysis of diluted biological solutions.

Gentile F, Coluccio ML, Coppedè N, Mecarini F, Das G, Liberale C, Tirinato L, Leoncini M, Perozziello G, Candeloro P, De Angelis F, Di Fabrizio E.

ACS Appl Mater Interfaces. 2012 Jun 27;4(6):3213-24. doi: 10.1021/am300556w. Epub 2012 Jun 4.

PMID:
22620470
32.

Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitus.

Porcellati F, Lucidi P, Rossetti P, Candeloro P, Andreoli AM, Marzotti S, Cioli P, Bolli GB, Fanelli CG.

Diabetes Care. 2011 Dec;34(12):2521-3. doi: 10.2337/dc11-1064. Epub 2011 Oct 4.

33.

Nanoparticle microinjection and Raman spectroscopy as tools for nanotoxicology studies.

Candeloro P, Tirinato L, Malara N, Fregola A, Casals E, Puntes V, Perozziello G, Gentile F, Coluccio ML, Das G, Liberale C, De Angelis F, Di Fabrizio E.

Analyst. 2011 Nov 7;136(21):4402-8. doi: 10.1039/c1an15313g. Epub 2011 Aug 30.

PMID:
21879030
34.

Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study.

Lucidi P, Porcellati F, Rossetti P, Candeloro P, Cioli P, Marzotti S, Andreoli AM, Fede R, Bolli GB, Fanelli CG.

Diabetes Care. 2011 Jun;34(6):1312-4. doi: 10.2337/dc10-1911. Epub 2011 Apr 15.

35.

Highly efficient human serum filtration with water-soluble nanoporous nanoparticles.

Pujia A, De Angelis F, Scumaci D, Gaspari M, Liberale C, Candeloro P, Cuda G, Di Fabrizio E.

Int J Nanomedicine. 2010 Nov 19;5:1005-15. doi: 10.2147/IJN.S12865.

36.

Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context.

De Angelis F, Pujia A, Falcone C, Iaccino E, Palmieri C, Liberale C, Mecarini F, Candeloro P, Luberto L, de Laurentiis A, Das G, Scala G, Di Fabrizio E.

Nanoscale. 2010 Oct;2(10):2230-6. doi: 10.1039/c0nr00161a. Epub 2010 Sep 7.

PMID:
20835434
37.

Monitoring human leukocyte antigen class I molecules by micro-Raman spectroscopy at single-cell level.

Das G, La Rocca R, Lakshmikanth T, Gentile F, Tallerico R, Zambetti LP, Devitt J, Candeloro P, De Angelis F, Carbone E, Di Fabrizio E.

J Biomed Opt. 2010 Mar-Apr;15(2):027007. doi: 10.1117/1.3368687.

PMID:
20459281
38.

Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.

Lucidi P, Rossetti P, Porcellati F, Pampanelli S, Candeloro P, Andreoli AM, Perriello G, Bolli GB, Fanelli CG.

Diabetes. 2010 Jun;59(6):1349-57. doi: 10.2337/db09-0745. Epub 2010 Mar 18.

39.

FT-IR, Raman, RRS measurements and DFT calculation for doxorubicin.

Das G, Nicastri A, Coluccio ML, Gentile F, Candeloro P, Cojoc G, Liberale C, De Angelis F, Di Fabrizio E.

Microsc Res Tech. 2010 Oct;73(10):991-5. doi: 10.1002/jemt.20849. Review.

PMID:
20232462
40.

Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization.

Terracciano R, Casadonte F, Pasqua L, Candeloro P, Di Fabrizio E, Urbani A, Savino R.

Talanta. 2010 Feb 15;80(4):1532-8. doi: 10.1016/j.talanta.2009.03.060. Epub 2009 Apr 5.

PMID:
20082811
41.

Nanoscale chemical mapping using three-dimensional adiabatic compression of surface plasmon polaritons.

De Angelis F, Das G, Candeloro P, Patrini M, Galli M, Bek A, Lazzarino M, Maksymov I, Liberale C, Andreani LC, Di Fabrizio E.

Nat Nanotechnol. 2010 Jan;5(1):67-72. doi: 10.1038/nnano.2009.348. Epub 2009 Nov 22.

PMID:
19935647
42.

Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans.

Porcellati F, Rossetti P, Candeloro P, Lucidi P, Cioli P, Andreoli AM, Ghigo E, Bolli GB, Fanelli CG.

J Clin Endocrinol Metab. 2009 Aug;94(8):3017-24. doi: 10.1210/jc.2008-2838. Epub 2009 May 26.

PMID:
19470629
43.

Nano-patterned SERS substrate: application for protein analysis vs. temperature.

Das G, Mecarini F, Gentile F, De Angelis F, Mohan Kumar H, Candeloro P, Liberale C, Cuda G, Di Fabrizio E.

Biosens Bioelectron. 2009 Feb 15;24(6):1693-9. doi: 10.1016/j.bios.2008.08.050. Epub 2008 Sep 10.

PMID:
18976899
44.

Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans.

Rossetti P, Porcellati F, Lucidi P, Busciantella Ricci N, Candeloro P, Cioli P, Santeusanio F, Bolli GB, Fanelli CG.

Diabetes. 2009 Jan;58(1):194-202. doi: 10.2337/db08-0641. Epub 2008 Oct 13.

45.

Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.

Rossetti P, Porcellati F, Busciantella Ricci N, Candeloro P, Cioli P, Nair KS, Santeusanio F, Bolli GB, Fanelli CG.

Diabetes. 2008 Jul;57(7):1905-17. doi: 10.2337/db08-0276. Epub 2008 Apr 4.

46.

Observation of coherence and partial decoherence of quantized spin waves in nanoscaled magnetic ring structures.

Schultheiss H, Schäfer S, Candeloro P, Leven B, Hillebrands B, Slavin AN.

Phys Rev Lett. 2008 Feb 1;100(4):047204. Epub 2008 Jan 31.

PMID:
18352326
47.

High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency.

Tsigkou A, Marzotti S, Borges L, Brozzetti A, Reis F, Candeloro P, Luisa Bacosi M, Bini V, Petraglia F, Falorni A.

J Clin Endocrinol Metab. 2008 Apr;93(4):1263-9. doi: 10.1210/jc.2007-1675. Epub 2008 Jan 22.

PMID:
18211971
48.

Different brain responses to hypoglycemia induced by equipotent doses of the long-acting insulin analog detemir and human regular insulin in humans.

Rossetti P, Porcellati F, Ricci NB, Candeloro P, Cioli P, Bolli GB, Fanelli CG.

Diabetes. 2008 Mar;57(3):746-56. Epub 2007 Dec 14.

49.

MICA gene polymorphism in the pathogenesis of type 1 diabetes.

Gambelunghe G, Brozzetti A, Ghaderi M, Candeloro P, Tortoioli C, Falorni A.

Ann N Y Acad Sci. 2007 Sep;1110:92-8.

PMID:
17911424
50.

Mapping of human autoantibody epitopes on aromatic L-amino acid decarboxylase.

Candeloro P, Voltattorni CB, Perniola R, Bertoldi M, Betterle C, Mannelli M, Giordano R, De Bellis A, Tiberti C, Laureti S, Santeusanio F, Falorni A.

J Clin Endocrinol Metab. 2007 Mar;92(3):1096-105. Epub 2007 Jan 2.

PMID:
17200166

Supplemental Content

Loading ...
Support Center